FDA issues long-awaited draft software guidance in overhaul of 16-year-old policy

Bradley Merrill Thompson, an attorney at Epstein Becker Green, said the new guidance is sorely needed by the medical device industry. “In the realm of software, [16 years is] an eternity,” Thompson said.